Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Julia Huamani-Zavala"'
Autor:
Domingo Morales, Jorge Castillo-Aguirre, Luis Riva, Osbert Mejía, Miriam Vidurrizaga, Brady E. Beltrán-Gárate, Antonio A. Carrasco-Yalan, Fernando Hurtado de Mendoza, Julia Huamani-Zavala, Pilar Quiñones, Jose M Malaga
Publikováno v:
Blood. 108:4760-4760
BACKGROUND: Foxp3 is a key regulatory gene required for the development and function of: regulatory CD4+CD25high T cells (Treg) specialized in maintaining the balance between immunity and tolerance and activated conventional CD4+CD25low T cells witho
Autor:
Henry L. Gómez-Moreno, Alfredo Aronés-Valdivia, Brady E. Beltrán-Gárate, Julia Huamani-Zavala, Fernando Hurtado de Mendoza, Antonio A. Carrasco-Yalan
Publikováno v:
Blood. 108:4728-4728
Objectives: Alemtuzumab (Campath®/Mabcampath®, a humanized anti-CD52 monoclonal antibody) has shown to be effective in the treatment of diverse hematological malignancies, including B-cell chronic lymphocytic leukemia and T-cell prolymphocytic leuk
Autor:
Pilar Quiñones-Avila, Jorge Castillo-Aguirre, Brady E. Beltrán-Gárate, Sergio A. Murillo-Vizcarra, Olga M. Lopéz-Odría, Julia Huamani-Zavala, Luis Riva-Gonzales, Jorge S. Valdés-Gómez, Fernando Cauvi-R, Antonio A. Carrasco-Yalan
Publikováno v:
Blood. 106:4769-4769
HCL is a chronic leukemia of B-lymphocyte with variable clinical course: symptomatic cytopenia and/or marked splenomegaly. Concomitant infections disease are often and transfusion are quite necessary. Current therapy includes interferon, 2′deoxycof